Jason W Mastaitis
6PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 14, 2026
Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity.Joseph L Herman, Peter Dornbos, Karl Landheer
|May 13, 2025
GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates.Jason W Mastaitis, Daniel Gomez, José G Raya
|May 13, 2025
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial.Dinko Gonzalez Trotter, Stephen Donahue, Chris Wynne
|Sep 11, 2024
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone.Michael E Dunn, Aaron Kithcart, Jee Hae Kim
|Nov 22, 2023
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.Judith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska
|Apr 29, 2017
Activin A more prominently regulates muscle mass in primates than does GDF8.Esther Latres, Jason Mastaitis, Wen Fury
Pageof 1
Frequent Collaborators
3 joint publications
Judith Y Altarejos
3 joint publications
Andrew J Murphy
2 joint publications
Aris Baras
2 joint publications
Mark W Sleeman
2 joint publications
David J Glass
2 joint publications
Gary A Herman
1 joint publications
Trevor Stitt
1 joint publications
Jonathan Marchini
1 joint publications
Maria Foss-Freitas
1 joint publications
Adam H Neidert
